Shenzhen Mindray Bio-Medical Electronics | Sustainability & Chart

CNE100003G67

Basic information on Shenzhen Mindray Bio-Medical Electronics

Location: China

Industry: Manufacturing

Website

Impact Score

Description Shenzhen Mindray Bio-Medical Electronics

A company specializing in medical devices, instruments, and reagents, serving hospitals and healthcare providers globally.

Shenzhen Mindray Bio-Medical Electronics Sustainability Performance

Climate

11%

Renewable Energy

Shenzhen Mindray Bio-Medical Electronics obtains 24,8% of its energy from renewable energies. Target value per method: min. 100%

Greenhouse Gas Emissions

Shenzhen Mindray Bio-Medical Electronics emits 6,9 times its CO₂ budget of 11,606 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Supply Chain

Taking into account the entire supply chain, Shenzhen Mindray Bio-Medical Electronics emits 15,8 times its CO₂ budget of 11,606 tons of CO₂ equivalent. Target value per method: max. 100% of CO₂ budget

Recycling and Recovery of Waste

No data available for Shenzhen Mindray Bio-Medical Electronics. Target value per method: min. 75%

Society

70%

Union Formation and Collective Bargaining Power

Shenzhen Mindray Bio-Medical Electronics issues 100% collective agreements. Target value per method: min. 80%

CEO Pay Ratio

No data available for Shenzhen Mindray Bio-Medical Electronics. Target value per method: max. 20-30 times

Employee Turnover Rate

Shenzhen Mindray Bio-Medical Electronics has an employee turnover rate of 12,9%. Target value per method: max. 10%

Harassment and Discrimination at the Workplace

Shenzhen Mindray Bio-Medical Electronics meets 4 quality criteria for handling harassment and discrimination at the workplace. Target value per method: 4 quality criteria

Gender

47%

Women on Board

Shenzhen Mindray Bio-Medical Electronics has 27,3% women across its top leadership and supervisory bodies. Target value per method: min. 40%

Gender Pay Gap

No data available for Shenzhen Mindray Bio-Medical Electronics. Target value per method: max. 3%

Women in Management

Shenzhen Mindray Bio-Medical Electronics employs 21,1% female managers. Target value per method: min. 40%

Glass Ceiling

The proportion of women in senior management at Shenzhen Mindray Bio-Medical Electronics is 60,5% of the proportion of women in the overall workforce. Target value per method: min. 90%

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

Renewable Energy

Greenhouse Gas Emissions

Supply Chain

Waste Recycling

Sustainable [100]

Almost sustainable [67-99]

Moderate [34-66]

Not sustainable [0-33]

No data

We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

Compare Shenzhen Mindray Bio-Medical Electronics with ...

Shenzhen Mindray Bio-Medical Electronics

?

Impact Score

Climate

Society

Gender

11%

70%

47%

Shenzhen Mindray Bio-Medical Electronics

?

Impact Score

Climate

Society

Gender

Sources of sustainability performance

Metric	Value	Unit	Year	PDF Name	PDF Page
Employee Turnover Rate
Employee turnover	12,9	%	2025	mindray-2025-esg-report-en.pdf	129
Glass Ceiling
Women in management	21,05	%	2025	mindray-2025-esg-report-en.pdf	100
Women in workforce	34,78	%	2025	mindray-2025-esg-report-en.pdf	89
Greenhouse Gas Emissions
Number of employees	2 388	people	2025	mindray-2025-esg-report-en.pdf	88
Scope 1 emissions	7 115,56	Tonnes of CO2 equivalent	2025	mindray-2025-esg-report-en.pdf	127
Scope 2 emissions, location based	73 003,34	Tonnes of CO2 equivalent	2025	mindray-2025-esg-report-en.pdf	127
Harassment and Discrimination at the Workplace
Confidentiality mechanisms	Yes		2025	mindray-2025-esg-report-en.pdf	30
Incident notification mechanism	Yes		2025	mindray-2025-esg-report-en.pdf	29
Anti-discrimination policy	Yes		2025	mindray-2025-esg-report-en.pdf	122
Retaliation safeguards	Yes		2025	mindray-2025-esg-report-en.pdf	30
Renewable Energy
Total renewable energy consumption	6 617	tce	2025	mindray-2025-esg-report-en.pdf	127
Total energy consumption	26 703	tce	2025	mindray-2025-esg-report-en.pdf	126
Supply Chain
Scope 2 emissions, location based	73 003,34	Tonnes of CO2 equivalent	2025	mindray-2025-esg-report-en.pdf	127
Scope 1 emissions	7 115,56	Tonnes of CO2 equivalent	2025	mindray-2025-esg-report-en.pdf	127
Number of employees	2 388	people	2025	mindray-2025-esg-report-en.pdf	88
Scope 3 emissions	103 473,06	Tonnes of CO2 equivalent	2025	mindray-2025-esg-report-en.pdf	127
Union Formation and Collective Bargaining Power
Collective bargaining agreements coverage	100	%	2025	mindray-2025-esg-report-en.pdf	99
Women on Board
Women on supervisory board	3	people	2025	mindray-2025-esg-report-en.pdf	22
Supervisory board size	11	people	2025	mindray-2025-esg-report-en.pdf	22
Women in Management
Women in management	21,05	%	2025	mindray-2025-esg-report-en.pdf	100

Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

Find more sustainable companies

Home Find Companies & ETFs Learn to invest Academy Glossary Our Method

Imprint Privacy Policy GTC FAQContact Us

© 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support! Reference data includes information from ESMA FIRDS that has been transformed and enriched by money:care. The use of this reference data does not constitute endorsement of or support for money:care or its products by ESMA. Fund information is based in part on publications by the respective providers and has been processed by money:care. Logos provided by Logo.dev